精活速治疗少弱精子症疗效观察  被引量:7

Therapeutic effect of Jinghuosu on oligospermia and asthenospermia

在线阅读下载全文

作  者:刘德风[1] 商学军[2] 戴继灿[3] 鄢桃飞[4] 刘智勇[4] 谷龙杰[5] 纪亚忠[6] 陈磊[7] 姜辉[8] 

机构地区:[1]北京大学第三医院生殖男科,北京100191 [2]南京军区南京总医院男科,江苏南京210002 [3]上海交通大学附属仁济医院泌尿外科,上海200240 [4]第二军医大学附属长海医院泌尿外科,上海200433 [5]华中科技大学附属同济医院泌尿外科,湖北武汉430030 [6]同济大学附属同济医院泌尿外科,上海200065 [7]上海中医药大学附属龙华医院泌尿外科,上海200032 [8]北京大学第三医院泌尿外科,北京100191

出  处:《中华男科学杂志》2017年第3期227-230,共4页National Journal of Andrology

摘  要:目的:探讨精活速治疗少弱精子症的有效性。方法:120例特发性轻中度少、弱精子症患者入选本研究;口服精活速,1袋/次,2次/d,连续3个月;分别于治疗前及治疗后第1、2、3个月末,采用计算机辅助精液分析检测治疗前后每次射精后精液的各项参数变化(精子浓度、精子总活力、前向运动精子百分率、正常形态精子百分率),每次随访均记录患者有无明显不良反应。结果:治疗3个月后,入组患者的精液质量有了较明显的改善。精液中精子浓度、精子总活动率、前向运动精子百分率和精子形态正常百分率,在服用精活速治疗3个月后均有了较明显的改善(P<0.05),观察的3个月期间内,未见明显不良反应。结论:精活速治疗轻中度少弱精子症患者症疗效显著,无明显不良反应。Objective :To investigate the effects of the compound preparation Jinghuosu on oligospermia and asthenospermia. Meth- ods : This multi-centered clinical study included 120 cases of mild to moderate idiopathic oligospermia or asthenospermia, all treated with oral Jinghuosu once a bag, bid, for 3 successive months. Before and at 1,2 and 3 months after treatment, we detected sperm concentration, total sperm motility, progressive sperm motility and normal sperm morphology of each ejaculate, and recorded whether the patients had any adverse reactions. Results : After 3 months of treatment, all the patients showed obvious improvement in semen parameters, most significantly in sperm concentration, total sperm motility, and the percentages of progressive motile sperm and morphologically normal sperm (P 〈 0.05). No significant adverse reactions were observed during the 3 months of medication. Conclusion : Jinghuosu has a significant efficacy and no obvious adverse effect in the treatment of mild to moderate oligospermia and asthenospermia.

关 键 词:精活速 男性不育 少精子症 弱精子症 

分 类 号:R698.2[医药卫生—泌尿科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象